Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

被引：4
|
作者：
Kunte, Ameya Shrinivas [1 ]
Gagelmann, Nico [1 ]
Badbaran, Anita [1 ]
Berger, Carolina [2 ]
Massoud, Radwan [1 ]
Klyuchnikov, Evgeny [1 ]
Wolschke, Christine [1 ]
Janson, Dietlinde [1 ]
Fritsche-Friedland, Ulrike [2 ]
Fehse, Boris [2 ]
Kroeger, Nicolaus [1 ]
Ayuk, Francis A. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-168667
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：7531 / 7532
页数：2
相关论文
共 50 条
  • [41] Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
    Zhongfei Tao
    Zuzana Chyra
    Jana Kotulová
    Piotr Celichowski
    Jana Mihályová
    Sandra Charvátová
    Roman Hájek
    Blood Cancer Journal, 14 (1)
  • [42] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
    Zhu, Haibo
    Deng, Haobin
    Mu, Juan
    Lyu, Cuicui
    Jiang, Yanyu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
  • [43] Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review
    Perez-Moreno, Maria Antonia
    Ciudad-Gutierrez, Pablo
    Jaramillo-Ruiz, Didiana
    Reguera-Ortega, Juan Luis
    Abdel-kader Martin, Laila
    Flores-Moreno, Sandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [44] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [45] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [46] Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
    Bruce L. Levine
    Marcelo C. Pasquini
    John E. Connolly
    David L. Porter
    Michael P. Gustafson
    Jaap J. Boelens
    Edwin M. Horwitz
    Stephan A. Grupp
    Marcela V. Maus
    Frederick L. Locke
    Fabio Ciceri
    Annalisa Ruggeri
    John Snowden
    Helen E. Heslop
    Crystal L. Mackall
    Carl H. June
    Anna M. Sureda
    Miguel-Angel Perales
    Nature Medicine, 2024, 30 : 338 - 341
  • [47] Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress
    Huageng Huang
    Le Yu
    Huawei Weng
    Wei Zhang
    Zhao Wang
    Lin Wang
    He Huang
    Journal of Hematology & Oncology, 17 (1)
  • [48] Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
    Levine, Bruce L.
    Pasquini, Marcelo C.
    Connolly, John E.
    Porter, David L.
    Gustafson, Michael P.
    Boelens, Jaap J.
    Horwitz, Edwin M.
    Grupp, Stephan A.
    Maus, Marcela V.
    Locke, Frederick L.
    Ciceri, Fabio
    Ruggeri, Annalisa
    Snowden, John
    Heslop, Helen E.
    Mackall, Crystal L.
    June, Carl H.
    Sureda, Anna M.
    Perales, Miguel-Angel
    NATURE MEDICINE, 2024, 30 (03) : 338 - 341
  • [49] CAR-T and other adoptive cell therapies for B cell malignancies
    Lu, Peihua
    Hill, Holly A.
    Navsaria, Lucy J.
    Wang, Michael L.
    JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (03): : 88 - 96
  • [50] CLINICAL EFFICACY OF CAR-T AND CAR-NK FOR THE TREATMENT OF HEMATOLOGIC AND SOLID TUMOR MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Chowdhury, S.
    Mugundu, G.
    Li, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S19 - S19
12345